|
|||||
|
|
Disease Control as a Predictor of Survival with Gefitinib and Docetaxel in a Phase III Study (V-15-32) in Advanced Non-small Cell Lung Cancer Patients |
|
| Authors: | Nobuyuki Yamamoto Yutaka Nishiwaki Shunichi Negoro Haiyi Jiang Yohji Itoh Nagahiro Saijo Masahiro Fukuoka |
| Affiliation: | 2. Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan;3. Department of Thoracic Oncology, Hyogo Cancer Center, Hyogo, Japan;4. AstraZeneca KK, Osaka, Japan; and Department of Medical Oncology, Kinki University School of Medicine, Osaka, Japan |
| Abstract: | |
| Keywords: | Docetaxel Epidermal growth factor receptor tyrosine kinase inhibitors Gefitinib Landmark analysis NSCLC |
| 本文献已被 ScienceDirect 等数据库收录！ | |